ArticleObesity surgery2022
Five Years of MBSAQIP Data: Characteristics, Outcomes, and Trends for Patients with Super-obesity.
Article in Obesity surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 27 citations in OpenAlex.
- Treating Severe Obesity: A Medical Perspective.Advances in therapy · 2026Review
- Differences in utilization and outcomes for laparoscopic versus robotic cholecystectomy in patients with class IV obesity: a retrospective cohort analysis of the NSQIP database.Surgical endoscopy · 2026Article
- When BMI exceeds 50: what ten years of follow-up reveal after bariatric surgery (BARI-10-POL study).Scientific reports · 2026Observational
- In-hospital outcomes following sleeve gastrectomy and Roux-en-Y gastric bypass: a real-world multicenter study in Germany.Langenbeck's archives of surgery · 2026Article
- Evaluating National Trends in Bleeding Associated with Metabolic Bariatric Surgery over 7 Years.Obesity surgery · 2025Article
- Trends and Outcomes of Metabolic Surgery in Adolescents with BMI ≥ 50 vs < 50 kg/mObesity surgery · 2025Article
- SF-BARI Score for Assessment of Long-Term Results in Patients with BMI ≥ 50 kg/mObesity surgery · 2025Article
- Effectiveness of robotic metabolic and bariatric surgery in patients with BMI ≥ 50-59.9 and BMI ≥ 60 for the treatment of severe obesity in a national medical center in Mexico.Journal of robotic surgery · 2024Article
- Predictors and Outcomes Associated with Bariatric Robotic Delivery: An MBSAQIP Analysis of 318,151 Patients.Journal of clinical medicine · 2024Article
- Analysis of the 1-year efficacy of four different surgical methods for treating Chinese super obese (BMI ≥ 50 kg/mScientific reports · 2024Observational
- Does ASA classification effectively risk stratify patients undergoing bariatric surgery: a MBSAQIP retrospective cohort of 138,612 of patients.Surgical endoscopy · 2023Article
- Characteristics and outcomes for patients undergoing revisional bariatric surgery due to persistent obesity: a retrospective cohort study of 10,589 patients.Surgical endoscopy · 2023Article
- Comparative Safety of Sleeve Gastrectomy and Gastric Bypass up to 5 Years After Surgery in Patients With Medicaid.Annals of surgery · 2023Article
- Weight loss outcomes for patients undergoing conversion to Roux-en-Y-gastric bypass after sleeve gastrectomy.Surgical endoscopy · 2023Article
- The paradox of Zeno in bariatric surgery weight loss: Superobese patients run faster than morbidly obese patients, but can't overtake them.Frontiers in surgery · 2023Article
- Patient Selection and 30-Day Outcomes of SADI-S Compared to RYGB: a Retrospective Cohort Study of 47,375 Patients.Obesity surgery · 2022Article
- Effect of the COVID-19 pandemic on bariatric surgery in North America: a retrospective analysis of 834,647 patients.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2022Article
- Article
- Trends in the Utilization of Intragastric Balloons: a 5-Year Analysis of the MBSAQIP Registry.Obesity surgery · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIncidence of super obesity (SO; BMI ≥ 50 kg/m MATERIALS AND
methodsThe MBSAQIP database was analyzed, and two cohorts were compared, those with SO and non-SO. Univariate analysis was performed to determine between-group differences. Multivariable logistic regression analysis was performed to determine if SO was independently associated with serious complications or mortality.
resultsWe evaluated 751,952 patients with 173,110 (23.0%) having SO. Patients with SO were younger (42.2 ± 11.8 SO vs 45.1 ± 12.0 years non-SO, p < 0.001) and less likely to be female (74.8% vs 81.1%, p < 0.001). While comorbidities seem to be decreasing overall in bariatric surgery patients, those with SO have worse functional capacity and more endocrine, pulmonary, and vascular comorbidities. Patients with SO also have worse 30-day postoperative complications, and SO was independently associated with severe complications (OR 1.08; CI 1.05-1.11, p < 0.001) and mortality (OR 2.49; CI 2.12-2.92, p < 0.001)
conclusionsPatients with SO have significantly increased preoperative comorbidities resulting in worse postoperative outcomes. SO remains an independent risk factor for serious complications and the greatest independent risk factor for 30-day postoperative mortality. Considering the expected increase in patients with SO, substantial work is required to optimize bariatric surgery strategies specific to these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.